or Try an Advanced Search...

    Technical Analysis for SONN - SONNET BioTherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.76 -1.68% -0.03
    SONN closed down 1.68 percent on Wednesday, May 8, 2024, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SONN trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Earnings Movers Other 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    50 DMA Resistance Bearish -1.68%
    Fell Below 20 DMA Bearish -1.68%
    Bollinger Band Squeeze Range Contraction -1.68%
    BB Squeeze Started Range Contraction -1.68%
    Older End-of-Day Signals for SONN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 12 hours ago
    Possible Inside Day about 12 hours ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 3% 1 day ago
    20 DMA Support 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SONN Chart by TradingView
    Basic chart:

    Profile

    SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Biology Immunology Antibody Cytokine Blood Plasma Biochemistry

    Is SONN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 11 Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
    Feb 29 Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
    Feb 14 Sonnet BioTherapeutics GAAP EPS of -$0.31, revenue of $18.63M
    Feb 14 Sonnet BioTherapeutics GAAP EPS of -$0.31
    Feb 14 Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
    Dec 22 Sonnet BioTherapeutics files for $100M mixed shelf
    Dec 21 Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
    See more SONN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.4
    52 Week Low 1.08
    Average Volume 115,395
    200-Day Moving Average 2.66
    50-Day Moving Average 1.90
    20-Day Moving Average 1.81
    10-Day Moving Average 1.81
    Average True Range 0.12
    RSI (14) 44.44
    ADX 12.8
    +DI 20.45
    -DI 24.04
    Chandelier Exit (Long, 3 ATRs) 1.74
    Chandelier Exit (Short, 3 ATRs) 2.01
    Upper Bollinger Bands 1.99
    Lower Bollinger Band 1.63
    Percent B (%b) 0.35
    BandWidth 19.62
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram 0.0018
    Fundamentals Value
    Market Cap 5.4 Million
    Num Shares 3.07 Million
    EPS -18.14
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 29.80
    Price-to-Book 19.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.83
    Resistance 3 (R3) 1.84 1.82 1.82
    Resistance 2 (R2) 1.82 1.80 1.82 1.81
    Resistance 1 (R1) 1.79 1.79 1.78 1.78 1.81
    Pivot Point 1.78 1.78 1.77 1.77 1.78
    Support 1 (S1) 1.75 1.76 1.74 1.74 1.71
    Support 2 (S2) 1.73 1.75 1.73 1.71
    Support 3 (S3) 1.70 1.73 1.70
    Support 4 (S4) 1.69